T2 Biosystems (NASDAQ:TTOO – Get Free Report) had its target price dropped by equities researchers at Canaccord Genuity Group from $12.00 to $3.00 in a research note issued on Monday, Benzinga reports. The firm currently has a “hold” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target would suggest a potential upside […]